Dawei Bu
Impact in
-
- Protease and Inhibitor Mechanisms
- Cancer Genomics and Diagnostics
-
- Inflammatory Biomarkers in Disease Prognosis
- Chemokine receptors and signaling
Papers in ⓘ
-
- Epigenetics and DNA Methylation 4
- DNA Repair Mechanisms 3
- Oncology 10
- Cancer Risks and Factors 3
- Chemokine receptors and signaling 2
- Cancer Cells and Metastasis 2
- Co-authors
- Cheryl Lewis (9 shared papers)David Euhus (8 shared papers)Xian‐Jin Xie (3 shared papers)Sara Milchgrub (2 shared papers)A. Marilyn Leitch (2 shared papers)Aihua Bian (2 shared papers)Jian Tang (3 shared papers)Leslie Cler (2 shared papers)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (4 papers)Breast Cancer Research and Treatment (2 papers)Protein Expression and Purification (2 papers)Blood (2 papers)Scandinavian Journal of Gastroenterology (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Dawei Bu
23 papers receiving 481 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 125
- Oncology 147
- Immunology and Allergy 28
- Molecular Biology 278
- Internal Medicine 14
Countries citing papers authored by Dawei Bu
This map shows the geographic impact of Dawei Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Bu more than expected).
Fields of papers citing papers by Dawei Bu
This network shows the impact of papers produced by Dawei Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Bu. The network helps show where Dawei Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 75 | |
| 2 | 2008 | 64 | |
| 3 | 2019 | 54 | |
| 4 | 2012 | 46 | |
| 5 | 2007 | 42 | |
| 6 | 2006 | 32 | |
| 7 | 2006 | 27 | |
| 8 | 2013 | 24 | |
| 9 | 2007 | 24 | |
| 10 | 2011 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2013 | 11 | |
| 13 | 2006 | 10 | |
| 14 | 2011 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2018 | 7 | |
| 19 | 2011 | 2 | |
| 20 | 2004 | 2 |
About Dawei Bu
Dawei Bu is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Hematology, having authored 24 papers that have together received 486 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Platelet Disorders and Treatments (4 papers), DNA Repair Mechanisms (3 papers), Cancer Risks and Factors (3 papers), Chemokine receptors and signaling (2 papers), Complement system in diseases (2 papers), Cell Adhesion Molecules Research (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (125 citations), Oncology (147 citations), Immunology and Allergy (28 citations), Molecular Biology (278 citations) and Internal Medicine (14 citations). Dawei Bu has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Cheryl Lewis, David Euhus, Xian‐Jin Xie, Sara Milchgrub, A. Marilyn Leitch, Aihua Bian, Jian Tang, Leslie Cler, Suying Dang and Bi‐Sen Ding. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Breast Cancer Research and Treatment, Protein Expression and Purification, Blood and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.